GSK-A1及其衍生物的合成

设计了一条新的合成路线,以5-溴-2-甲氧基吡啶、吗啉、2-氟苯胺和联硼酸频那醇酯等为原料,经硝化、磺酰化、硼酸酯化和Suzuki-Miyaura等反应得到目标产物GSK-A1,总收率达到19.33 %。并在该工艺基础上设计合成了9个新的衍生物,其结构经¹H NMR和HR-MS（ESI-TOF）确证。     

非包覆型油井水泥自修复剂的制备与评价

采用反向悬浮聚合法,丙烯酸(AA)和丙烯酰胺(AM)为单体,过硫酸钾（KBS）作引发剂,N,N-亚甲基双丙烯酰胺(MBA)作交联剂,制备了一种非包覆遇水膨胀型自修复剂LF-1,其结构经SEM和IR表征。结果表明,LF-1分散均匀,表观形态呈多孔、粗糙褶皱状。将2%LF-1加入水泥浆中,水泥浆流动度为20.1 cm,失水52 mL,稠化时间217 min;用5000 mg/L的盐水养护造缝水泥石,12 h内即无渗透性;水泥石24 h抗压强度为16.1 MPa,抗折强度为4.92 MPa。      

热活化延迟荧光蓝光小分子取代基效应的研究进展

近年来,作为第三代有机发光二极管(organic light-emitting diodes, OLED)发光材料的热活化延迟荧光(thermally activated delayed fluorescence, TADF)材料受到了学术界和产业界的广泛关注. TADF分子由于其单线态与三线态之间的能级差较小,三线态激子可以被环境热活化而通过反系间窜越上转换至单线态,理论上可实现100%的激子利用率,从而使得OLED器件外量子效率显著提高.TADF材料被认为是突破高效稳定有机电致蓝光发射瓶颈的潜在解决方案.一般, TADF分子为含有电子给体(donor, D)和电子受体(acceptor, A)的纯有机推拉电子体系.通过改变给体单元和受体单元的结构、数量和取代基及其位置可以有效调节TADF分子的单线态-三线态能级差、前线轨道分布、聚集态结构、电致发光颜色及其性能.同时取代基在调控给、受体单元的推拉电子能力及TADF材料的分子构型、聚集态结构和稳定性等物化特性方面扮演着非常重要的角色.本综述分别对D-A型和多重共振型TADF蓝光分子的取代基效应进行了综述,以期为高效稳定的蓝光TADF分...     

Insight into the reaction mechanism of sulfur chains adjustable polymer cathode for high-loading lithium-organosulfur batteries

Small molecules with adjustable sulfur atoms in the confined structure were acted as precursor for the synthesis of polymer cathodes for lithium-organosulfur batteries.Among them,poly(diallyl tetrasulfide)(PDATtS)delivered a high capacity of 700 mAh g^-1,stable capacity retention of 85%after 300 cycles,high areal capacity~4 m Ah cm^-2 for electrode with up to 10.3 mg cm^-2 loading.New insight into the reaction mechanism of PDATtS electrode that radicals arisen from the homolytic cleavage of S-S bond in PDATtS reacted with Li+to generate thiolates(RSLi)and insoluble lithium sulfides(Li₂S)or lithium disulfide(Li₂S₂)was clearly verified by in-situ UV/Vis spectroscopy,nuclear magnetic resonance(NMR)studies and density-functional theory(DFT)calculations.Therefore,based on the unique reaction mechanism,problems of rapid capacity fading due to the formation of soluble polysulfide intermediates and their serious shuttle effect in conventional lithium-sulfur(Li-S)batteries was totally avoided,realizing the dendrite-free lithium sulfur batteries.This study sets new trends for avenues of further research to advance Li-S battery technologies.     

CO/light dual-activatable Ru(ii)-conjugated oligomer agent for lysosome-targeted multimodal cancer therapeutics

Stimuli-activatable and subcellular organelle-targeted agents with multimodal therapeutics are urgently desired for highly precise and effective cancer treatment. Herein, a CO/light dual-activatable Ru(ii)-oligo-(thiophene ethynylene) (Ru-OTE) for lysosome-targeted cancer therapy is reported. Ru-OTE is prepared via the coordination-driven self-assembly of a cationic conjugated oligomer (OTE-BN) ligand and a Ru(ii) center. Upon the dual-triggering of internal gaseous signaling molecular CO and external light, Ru-OTE undergoes ligand substitution and releases OTE-BN followed by dramatic fluorescence recovery, which could be used for monitoring drug delivery and imaging guided anticancer treatments. The released OTE-BN selectively accumulates in lysosomes, physically breaking their integrity. Then, the generated cytotoxic singlet oxygen (¹O₂) causes severe lysosome damage, thus leading to cancer cell death via photodynamic therapy (PDT). Meanwhile, the release of the Ru(ii) core also suppresses cancer cell growth as an anticancer metal drug. Its significant anticancer effect is realized via the multimodal therapeutics of physical disruption/PDT/chemotherapy. Importantly, Ru-OTE can be directly photo-activated using a two-photon laser (800 nm) for efficient drug release and near-infrared PDT. Furthermore, Ru-OTE with light irradiation inhibits tumor growth in an MDA-MB-231 breast tumor model with negligible side effects. This study demonstrates that the development of an activatable Ru(ii)-conjugated oligomer potential drug provides a new strategy for effective subcellular organelle-targeted multimodal cancer therapeutics.

The anticancer therapeutics of lysosome disruption/PDT/chemotherapy based on Ru-OTE complex was achieved, which provides a new strategy for developing multimodal and effective stimuli-activatable subcellular organelle-targeted cancer therapeutics.     

Impact of Drying Methods on Phenolic Components and Antioxidant Activity of Sea Buckthorn (Hippophae rhamnoides L.) Berries from Different Varieties in China

Sea buckthorn berries are rich in bioactive compounds and can be used for medicine and food. The variety and drying method used have an important influence on quality. In this study, different sea buckthorn varieties from China were selected and dried with four common drying methods. The total phenolic content (TPC), total flavonoids content (TFC), contents of 12 phenolic compounds and antioxidant capacity in vitro were analyzed. The results showed that the TPC, TFC and antioxidant activity of two wild sea buckthorn berries were higher than those of three cultivated berries, and for the same varieties, measured chemical contents and antioxidant activity of the freeze-dried fruit were significantly higher than those obtained with three conventional drying methods. In addition, forty-one compounds in sea buckthorn berry were identified by UPLC-PDA-Q/TOF-MS, most of which were isorhamnetin derivatives. Multivariate statistical analysis revealed narcissin and isorhamnetin-3-O-glucoside varied significantly in sea buckthorn berries of different varieties and with different drying methods; they were potential quality markers. Strong correlations were found between TPC, gallic acid and antioxidant capacity (p < 0.05). The results revealed how components and antioxidant activity varied in different sea buckthorn, which provides a valuable reference for quality control and further development and utilization of sea buckthorn.     

Identification of Influenza PAN Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening

Structural and biochemical studies elucidate that PA_N may contribute to the host protein shutdown observed during influenza A infection. Thus, inhibition of the endonuclease activity of viral RdRP is an attractive approach for novel antiviral therapy. In order to envisage structurally diverse novel compounds with better efficacy as PA_N endonuclease inhibitors, a ligand-based-pharmacophore model was developed using 3D-QSAR pharmacophore generation (HypoGen algorithm) methodology in Discovery Studio. As the training set, 25 compounds were taken to generate a significant pharmacophore model. The selected pharmacophore Hypo1 was further validated by 12 compounds in the test set and was used as a query model for further screening of 1916 compounds containing 71 HIV-1 integrase inhibitors, 37 antibacterial inhibitors, 131 antiviral inhibitors and other 1677 approved drugs by the FDA. Then, six compounds (Hit01–Hit06) with estimated activity values less than 10 μM were subjected to ADMET study and toxicity assessment. Only one potential inhibitory ‘hit’ molecule (Hit01, raltegravir’s derivative) was further scrutinized by molecular docking analysis on the active site of PA_N endonuclease (PDB ID: 6E6W). Hit01 was utilized for designing novel potential PA_N endonuclease inhibitors through lead optimization, and then compounds were screened by pharmacophore Hypo1 and docking studies. Six raltegravir’s derivatives with significant estimated activity values and docking scores were obtained. Further, these results certainly do not confirm or indicate the seven compounds (Hit01, Hit07, Hit08, Hit09, Hit10, Hit11 and Hit12) have antiviral activity, and extensive wet-laboratory experimentation is needed to transmute these compounds into clinical drugs.     

One-Pot Facile Synthesis of Noble Metal Nanoparticles Supported on rGO with Enhanced Catalytic Performance for 4-Nitrophenol Reduction

In this study, reduced graphene oxide (rGO)-supported noble metal (gold, silver, and platinum) nanoparticle catalysts were prepared via the one-pot facile co-reduction technique. Various measurement techniques were used to investigate the structures and properties of the catalysts. The relative intensity ratios of I_D/I_G in rGO/Au, rGO/Ag, rGO/Pt, and GO were 1.106, 1.078, 1.047, and 0.863, respectively. The results showed the formation of rGO and that noble metal nanoparticles were decorated on rGO. Furthermore, the catalytic activities of the designed nanocomposites were investigated via 4-nitrophenol. The catalysts were used in 4-nitrophenol reduction. The catalytic performance of the catalysts was evaluated using the apparent rate constant k values. The k value of rGO/Au was 0.618 min⁻¹, which was higher than those of rGO/Ag (0.55 min⁻¹) and rGO/Pt (0.038 min⁻¹). The result proved that the rGO/Au catalyst exhibited a higher catalytic performance than the rGO/Ag catalyst and the rGO/Pt catalyst. The results provide a facile method for the synthesis of rGO-supported nanomaterials in catalysis.     

基于二氧化硅胶体晶体薄膜和反射干涉光谱的蛋白冠监测方法

生物分子与纳米材料作用形成的"蛋白冠"影响纳米材料的物理和化学性质,目前缺少有效的原位实时技术监测蛋白冠的形成过程.本研究基于二氧化硅胶体晶体薄膜和反射干涉光谱法,研究了三种代表性血液蛋白质在二氧化硅纳米粒子表面的蛋白冠形成过程,结果表明这三种蛋白具有不同的蛋白冠形成过程及参数;研究了人血清白蛋白在三种表面曲率的二氧化...     

活性氧响应的新型阳离子共聚物构建及其基因递送性能研究

引入快速、主动释放基因的机制是提升非病毒基因递送效率的关键. 本研究以2-甲基丙烯酰氧乙基磷酰胆碱(MPC)与(2-丙烯酰基)乙基(硼酸苄基)二乙基溴化铵(BD)为单体, 基于可逆加成-断裂链转移聚合(RAFT)反应制备具有活性氧响应性质的聚阳离子嵌段共聚物pM-pBD. 通过静电作用, 阳离子共聚物pM-pBD能够与带负电荷的DNA以分子自组装的方式形成纳米复合物. 其中, 阳离子pBD片段具有活性氧触发电荷反转的特性, 因此, 有助于获得活性氧触发的静电组装复合体结构解离, 从而实现可控基因释放的功能. 理化表征结果表明, pM-pBD与质粒DNA静电复合后能够形成粒径约为99.1 nm, ζ电位约为+13.8 mV, 显微形貌近似球形的纳米复合物. 在加入促过氧化氢产生的抗坏血酸后, 上述pM-pBD基因递送系统的转染效率得到了显著的提升. 因此, 本研究创制的pM-pBD为基因递送系统的可控释放提供了新的解决方案.